An interventional study of STAT-PC and YST-III in Suicide and Suicidal Ideation, sponsored by Elizabeth Arnold. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 24 Years. Per ClinicalTrials.gov, last updated 2025-11-06.
Sponsored by Elizabeth Arnold · Not applicable, Interventional, and Treatment
Among 349 studies in Suicidal Ideation with a site in United States — 109 open to participants now, 122 under way, 4 of them phase 3. Suicidal Ideation · United States.
Among the 349 studies in Suicidal Ideation with a site in United States, this one is the 12th largest by planned enrollment of the 320 interventional ones, is one of 34 that started in 2023, is one of 254 with no phase, reaches primary completion later than 44 of the 121 other live ones, and was the 241st registered.
569 studies on the registry are indexed under Suicidal Ideation; 203 are open to participants now.
This study's planned enrollment of 1,485 is above the median of 80 across 469 interventional studies indexed under Suicidal Ideation.
Browse Suicidal Ideation studies →109 of the 349 studies in Suicidal Ideation with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 134 Suicidal Ideation studies recruiting now, 51 (38%) set no upper age limit and 79 (59%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.
This study: 18 Years to 24 Years · all sexes · no healthy volunteers.
The full table on the hub →349 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 34 started in 2023.
Median enrollment 66 across the 320 interventional studies, 133 across the 29 observational. Of the 198 that completed or were terminated, 82 (41%) have results posted.
24 of 349 have an industry lead sponsor. The 10 most frequent:
Elizabeth Arnold is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Elizabeth Arnold has 1 study filed under Suicidal Ideation — fewer than ten, so there is no comparison to draw.
53 of the studies in Suicidal Ideation with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05696691Phase 3The University of Texas Health Science Center at San AntonioKetamine & Crisis Response Plan for Suicidal Ideation in the ED | 2026-12-31 |
| NCT07170657University of Texas Southwestern Medical CenterTeen Recovery Through Inspiration, Support, and Empowerment | 2026-11 |
| NCT06701006University of WashingtonIntegrated Suicide Supports and Safety Planning for Youth | 2026-11-01 |
| NCT06285708Ohio State UniversityEnhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD | 2026-12 |
| NCT05793541Massachusetts General HospitalJust-in-time Interventions for Reducing Short-term Suicide Risk | 2026-12 |
Among the 349 studies in Suicidal Ideation with a site in United States, from their registry updates:
The overall aim of this study is to reduce suicide among sexual and gender diverse youth ages 18-24 years old. This study will compare the effectiveness of two brief suicide prevention interventions that have been adapted for use with this population to use in primary care via telehealth and will recruit youth from primary care clinics in multiple metropolitan areas. The primary study outcome is suicidal ideation. Each clinic will be randomly assigned to deliver one of the two study interventions.
569 studies on the registry are indexed under Suicidal Ideation; 203 are open to participants now.
This study's planned enrollment of 1,485 is above the median of 80 across 469 interventional studies indexed under Suicidal Ideation.
Browse Suicidal Ideation studies →Elizabeth Arnold is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Compared within Suicidal Ideation, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Suicide. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group will participate in a brief, suicide prevention intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management that has been adapted.
Other: STAT-PC
This group will participate in a brief, suicide prevention intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation that has been adapted.
Other: YST-III
STAT-PC is an adapted version of Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED). It is a brief intervention based on motivational interviewing (MI) that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management. The intervention will consist of an initial session with the youth focusing on accessing mental health care plus case management calls. The interventionist will also be available to assist with referrals for connection to other services later during the study period as needed for up to three months. The intervention may include contact with the youth's mental health provider to make sure linkages are made.
Also known as: Suicidal Teens Accessing Treatment - Primary Care
YST-III is an adapted version of Youth-Nominated Support Team for Suicidal Adolescents (YST-II). The intervention is a brief intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation (SI). Participants will nominate supportive adults (age 18 and older) from their lives who agree to provide ongoing contact and support for up to 3 months. YST-III will include an introductory session with the youth who will nominate their support persons plus referrals for mental health services. The support persons will receive training and support on how to best support their youth partner and then ongoing calls to support them in working with their youth partner for up to 3 months.
Also known as: Youth-Nominated Support Team- III
Change in suicidal ideation as measured by the Adult Suicidal Ideation Questionnaire (ASIQ)
ASIQ is a 25-item, self-report assessment of suicidal thoughts designed specifically for adult populations. Possible scores range from 1 (Not at All) to 6 (Extreme), with lower scores indicating less severe suicidal ideation (better outcome).
Time frame: baseline and months 1, 3, 6
Change in number of mental healthcare service utilization as measured by Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) mental health service utilization check list
ED-STARS mental health service utilization check list will be used to assess the number of different types of mental health services that participants receive
Time frame: baseline and months 1, 3, 6
Change in number of suicide attempts
measured by the number of suicide attempts using the Columbia-Suicide Severity Rating Scale (CSSRS)
Time frame: baseline and months 1, 3, 6
Deaths by suicide
The data on any reported deaths due to suicide during the study period will be collected.
Time frame: baseline to 6 months
Change in depressive symptoms as measured by Center for Epidemiologic Studies Depression Scale-Revised CESD-R
CESD-R is a 20-item measure of depression that assesses the duration symptoms across a period of two weeks. Possible scores range from 0-60, with lower scores indicating less depressive symptoms (better outcome).
Time frame: baseline and months 1, 3, 6
Change in social support as measured by the Multidimensional Scale of Perceived Social Support (MSPSS)
12-item measure with three subscales that assesses family, friend, and significant other support. Response categories are on a 7-point Likert-scale from 1=very strongly disagree to 7=very strongly agree. The overall score will be used to assess change. The 12-item MSPSS scale has a mean continuous score ranging from 1-84. Higher scores indicate greater perceived social support (better outcome).
Time frame: baseline and months 1, 3, 6
Change in internalized stigma as measured by Internalized Transphobia Scale (ITS)-adapted
an adapted version of the Internalized Transphobia Scale (ITS). The measure consists of 22 questions. Possible score ranges from 1-4 with lower scores indicating less internalized stigma (better outcome)
Time frame: baseline and months 1, 3, 6
Plan to share: Yes — De-identified data will be deposited in the Patient-Centered Outcomes Data Repository as required by the funder.
Supporting information: Study protocol
Time frame: By the date that the Final Research Report is accepted by the funder
Access criteria: Researchers must go through the Patient-Centered Outcomes Data Repository to request access to the de-identified data through their process.
No publications or documents are linked to this record.
Started Jul 2023 (actual). Primary completion is estimated for Mar 2027, 44 months after the start.
Of 281 non-industry interventional studies with no phase under Suicidal Ideation, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 44 months is above that.
Counting every sponsor, half of 290 studies reached it within 29 months; a quarter within 13 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Elizabeth Arnold